Joint (NASDAQ:JYNT) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of Joint (NASDAQ:JYNT) from a strong-buy rating to a buy rating in a research report released on Sunday morning.

Several other brokerages have also recently issued reports on JYNT. Zacks Research cut shares of Joint from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Weiss Ratings lowered shares of Joint from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Reduce”.

Joint Price Performance

JYNT stock opened at $8.45 on Friday. The business has a 50 day moving average price of $8.78 and a 200 day moving average price of $8.82. The stock has a market cap of $119.48 million, a price-to-earnings ratio of 31.30 and a beta of 1.10. Joint has a fifty-two week low of $7.50 and a fifty-two week high of $11.14.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. The firm had revenue of $15.18 million during the quarter, compared to the consensus estimate of $14.57 million. Joint had a return on equity of 12.02% and a net margin of 6.49%. As a group, sell-side analysts anticipate that Joint will post 0.45 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Joint in the second quarter valued at approximately $2,534,000. Verus Capital Partners LLC boosted its holdings in shares of Joint by 23.6% in the first quarter. Verus Capital Partners LLC now owns 130,705 shares of the company’s stock valued at $1,157,000 after acquiring an additional 24,929 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Joint by 37.4% during the first quarter. Dimensional Fund Advisors LP now owns 153,754 shares of the company’s stock worth $1,361,000 after acquiring an additional 41,842 shares during the last quarter. Strs Ohio grew its position in shares of Joint by 17,300.0% during the first quarter. Strs Ohio now owns 17,400 shares of the company’s stock worth $154,000 after acquiring an additional 17,300 shares during the last quarter. Finally, Skylands Capital LLC increased its holdings in shares of Joint by 0.4% in the 1st quarter. Skylands Capital LLC now owns 893,195 shares of the company’s stock valued at $7,905,000 after acquiring an additional 3,150 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.